BNF for Children August 2022 Update

This update contains 2 significant changes, 1 dose change, 2 new monographs and 1 new preparation.

Significant Changes:

• Metformin hydrochloride: reduced vitamin B12 levels and new advice for monitoring patients at risk [MHRA/CHM advice].
• Type 1 diabetes: inclusion of continuous glucose monitoring in aims of treatment.

Dose Changes:

• Cyanocobalamin [update to indications and dose].

New Monographs:

• Bylvay® [odevixibat].
• Colchicine.

New Preparations: Uxil® [dasatinib].

For further details on changes in the BNFC click on https://www.medicinescomplete.com/#/content/bnfc/PHP107699?hspl=changes